These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39278778)

  • 1. Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT study.
    Mahajan K; Puri R; Duell PB; Dutta D; Yadav R; Kumar S; Sharma JB; Patel P; Dsouza S; Gupta A; Khan A; Wong ND
    J Clin Lipidol; 2024; 18(5):e867-e872. PubMed ID: 39278778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study.
    Masana L; Zambon A; Schmitt CP; Taylan C; Driemeyer J; Cohen H; Buonuomo PS; Alashwal A; Al-Dubayee M; Kholaif N; Diaz-Diaz JL; Maatouk F; Martinez-Hervas S; Mangal B; Löwe S; Cunningham T
    Lancet Diabetes Endocrinol; 2024 Dec; 12(12):880-889. PubMed ID: 39426393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia: The Randomized, Phase 3 REMAIN-2 Trial.
    Sun Y; Lv Q; Guo Y; Wang Z; Huang R; Gao X; Han Y; Yao Z; Zheng M; Luo S; Li Y; Gu X; Zhang Y; Wang J; Hong L; Ma X; Su G; Sheng J; Lai C; Shen A; Wang M; Zhang W; Wu S; Zheng Z; Li J; Zhong T; Wang Y; He L; Du X; Ma CS
    J Am Coll Cardiol; 2024 Nov; 84(20):2037-2047. PubMed ID: 39505412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Application of Evolocumab Among Patients with Hyperlipidemia in Korea: A Multicenter Prospective Study.
    Kim MC; Lee SH; Ahn JH; Lim Y; Park KI; Kim C; Ahn JH; Jeong J; Lee H; Kang WC
    Cardiol Ther; 2024 Dec; 13(4):695-706. PubMed ID: 39436637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asia-Pacific Real-World Evolocumab Use, LDL-C Reduction, Physician Goals, and Patient Perceptions: HALES Observational Study.
    Tse HF; Chang HY; Colquhoun D; Kim JS; Poh KK; Kostner K; Hutayanon P; Cho M; Lange J; Kodiappan K; Leekha S
    Cardiol Ther; 2024 Dec; 13(4):737-760. PubMed ID: 39455535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry.
    Navar AM; Shah NP; Shrader P; Thomas LE; Ahmad Z; Allred C; Chamberlain AM; Chrischilles EA; Dhalwani N; Effron MB; Hayek S; Jones LK; Kalich B; Shapiro MD; Wójcik C; Peterson ED
    Am Heart J; 2025 Jan; 279():107-117. PubMed ID: 38972336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Efficacy of Ezetimibe Combined with Rosuvastatin in the Treatment of Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Therapy.
    Wei Z; Wang F; Zhang L; Dai W
    Br J Hosp Med (Lond); 2024 Nov; 85(11):1-13. PubMed ID: 39618211
    [No Abstract]   [Full Text] [Related]  

  • 8. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial.
    Xu M; Wang Z; Zhang Y; Liu Y; Huang R; Han X; Yao Z; Sun J; Tian F; Hu X; Ma L; Lai C; Zhang X; Sheng J; Han Q; Jin C; Luo L; Zhao R; Li L; Xu B; Yin D; Luo S; Ge X; Liu Z; Yang P; Huang Z; Li T; Feng W; Wu Y; Ling Z; Ma L; Lv C; Deng C; Wei W; Wang Y; Yan L; Ge J;
    J Am Coll Cardiol; 2024 Nov; 84(20):2026-2036. PubMed ID: 39387764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry.
    D'Erasmo L; Bini S; Casula M; Gazzotti M; Bertolini S; Calandra S; Tarugi P; Averna M; Iannuzzo G; Fortunato G; Catapano AL; Arca M;
    Eur J Prev Cardiol; 2024 Jun; 31(8):1038-1047. PubMed ID: 38374534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.
    Lim AWY; Schneider L; Loy C
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD001747. PubMed ID: 39498781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial.
    Kim P; Sanchez AM; Penke TJR; Tuson HH; Kime JC; McKee RW; Slone WL; Conley NR; McMillan LJ; Prybol CJ; Garofolo PM
    Lancet Infect Dis; 2024 Dec; 24(12):1319-1332. PubMed ID: 39134085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Density Lipoprotein Cholesterol Goal Achievement and Self-Reported Medication Adherence: Insights from the JET-LDL Registry.
    Munafò AR; Ferlini M; Varbella F; Delnevo F; Solli M; Trabattoni D; Raone L; Cardile A; Canova P; Rossini R; Celentani D; Maltese L; Taglialatela V; Pierini S; Rognoni A; Oliva F; Porto I; Carugo S; Castiglioni B; Lettieri C; Chinaglia A; Currao A; Patti G; Visconti LO; Musumeci G
    Am J Cardiol; 2024 Dec; 233():55-61. PubMed ID: 39357617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early, Intensive and Persistent Lipid-Lowering Therapy for Secondary Prevention of Acute Coronary Syndrome.
    Okada K; Haze T; Kikuchi S; Kirigaya H; Hanajima Y; Tsutsumi K; Kirigaya J; Nakahashi H; Gohbara M; Kimura Y; Kosuge M; Ebina T; Sugano T; Hibi K
    J Atheroscler Thromb; 2024 Dec; 31(12):1748-1762. PubMed ID: 38880605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity?
    Mu W; Xu B; Wahafu T; Wang F; Guo W; Zou C; Cao L
    Clin Orthop Relat Res; 2024 Dec; 482(12):2149-2160. PubMed ID: 38991223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncontrolled Cholesterol in Individuals with Severe Hypercholesterolemia in a Health Evaluation Program in Brazil.
    Santos RD; Kashiwagi NM; Cesena FY; Assis SRL; Nieri J; Minanni CA; Franken M; Berwanger O
    Arq Bras Cardiol; 2024; 121(11):e20240116. PubMed ID: 39607222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring zinc deficiency using serum Zn levels: consequences and potential solutions in suckling pigs.
    Blavi L; Villagómez-Estrada S; Solà-Oriol D; Pérez JF
    J Anim Sci; 2024 Jan; 102():. PubMed ID: 38035764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Controlled Trial of a Novel Formulation of Ketorolac Tromethamine for Continuous Infusion (NTM-001) in Healthy Volunteers.
    Pergolizzi JV; Batra A; Schmidt WK
    Adv Ther; 2024 Feb; 41(2):659-671. PubMed ID: 38070041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world exploration of LDL-cholesterol management in patients with atherosclerotic cardiovascular disease.
    Shah NP; Mulder H; Lydon E; Chiswell K; Hu X; Lampron Z; Cohen L; Patel MR; Taubes S; Song W; Mulukutla SR; Saeed A; Morin DP; Bradley SM; Hernandez AF; Pagidipati NJ
    Am Heart J; 2025 Jan; 279():50-58. PubMed ID: 39423990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.